JP2001515895A5 - - Google Patents

Download PDF

Info

Publication number
JP2001515895A5
JP2001515895A5 JP2000510727A JP2000510727A JP2001515895A5 JP 2001515895 A5 JP2001515895 A5 JP 2001515895A5 JP 2000510727 A JP2000510727 A JP 2000510727A JP 2000510727 A JP2000510727 A JP 2000510727A JP 2001515895 A5 JP2001515895 A5 JP 2001515895A5
Authority
JP
Japan
Prior art keywords
acid
cvi
formula
hydroxylactone
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000510727A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001515895A (ja
JP4462760B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/017993 external-priority patent/WO1999012919A1/en
Publication of JP2001515895A publication Critical patent/JP2001515895A/ja
Publication of JP2001515895A5 publication Critical patent/JP2001515895A5/ja
Application granted granted Critical
Publication of JP4462760B2 publication Critical patent/JP4462760B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000510727A 1997-09-11 1998-09-03 プロテアーゼインヒビターとして有用な4−ヒドロキシ−2−オキソ−ピラン誘導体の製法 Expired - Lifetime JP4462760B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5861897P 1997-09-11 1997-09-11
US60/058,618 1997-09-11
PCT/US1998/017993 WO1999012919A1 (en) 1997-09-11 1998-09-03 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2009022289A Division JP5016621B2 (ja) 1997-09-11 2009-02-03 プロテアーゼインヒビターとして有用な4−ヒドロキシ−2−オキソ−ピラン誘導体の製法
JP2009280318A Division JP5266194B2 (ja) 1997-09-11 2009-12-10 プロテアーゼインヒビターとして有用な4−ヒドロキシ−2−オキソ−ピラン誘導体の製法

Publications (3)

Publication Number Publication Date
JP2001515895A JP2001515895A (ja) 2001-09-25
JP2001515895A5 true JP2001515895A5 (https=) 2006-01-05
JP4462760B2 JP4462760B2 (ja) 2010-05-12

Family

ID=22017924

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000510727A Expired - Lifetime JP4462760B2 (ja) 1997-09-11 1998-09-03 プロテアーゼインヒビターとして有用な4−ヒドロキシ−2−オキソ−ピラン誘導体の製法
JP2009022289A Expired - Lifetime JP5016621B2 (ja) 1997-09-11 2009-02-03 プロテアーゼインヒビターとして有用な4−ヒドロキシ−2−オキソ−ピラン誘導体の製法
JP2009280318A Expired - Lifetime JP5266194B2 (ja) 1997-09-11 2009-12-10 プロテアーゼインヒビターとして有用な4−ヒドロキシ−2−オキソ−ピラン誘導体の製法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009022289A Expired - Lifetime JP5016621B2 (ja) 1997-09-11 2009-02-03 プロテアーゼインヒビターとして有用な4−ヒドロキシ−2−オキソ−ピラン誘導体の製法
JP2009280318A Expired - Lifetime JP5266194B2 (ja) 1997-09-11 2009-12-10 プロテアーゼインヒビターとして有用な4−ヒドロキシ−2−オキソ−ピラン誘導体の製法

Country Status (20)

Country Link
US (2) US6077963A (https=)
EP (1) EP1015441B1 (https=)
JP (3) JP4462760B2 (https=)
KR (1) KR100569771B1 (https=)
CN (3) CN1284763C (https=)
AT (1) ATE266654T1 (https=)
CA (1) CA2300204C (https=)
CZ (1) CZ298847B6 (https=)
DE (1) DE69823844T2 (https=)
DK (1) DK1015441T3 (https=)
ES (1) ES2221199T3 (https=)
FI (1) FI120973B (https=)
HU (1) HU228986B1 (https=)
NO (1) NO321835B1 (https=)
NZ (1) NZ503338A (https=)
PL (1) PL193240B1 (https=)
PT (1) PT1015441E (https=)
RU (2) RU2223958C2 (https=)
SK (1) SK284974B6 (https=)
WO (1) WO1999012919A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3699100A (en) 1999-03-18 2000-10-04 Pharmacia & Upjohn Company Improved process for asymmetric hydrogenation
US6552204B1 (en) * 2000-02-04 2003-04-22 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
US6500963B2 (en) 2001-02-22 2002-12-31 Boehringer Ingelheim Pharma Kg Process for preparing optically active dihydropyrones
DE10108470A1 (de) * 2001-02-22 2002-09-05 Boehringer Ingelheim Pharma Verfahren zur Herstellung optisch aktiver Dihydropyrone
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
DE60234537D1 (de) 2002-02-07 2010-01-07 Sumitomo Chemical Co Verfahren zur herstellung von (r)-3-hydroxy-3-(2-phenylethyl) hexansäure und dessen zwischenprodukt
DE10313118A1 (de) 2003-03-24 2004-10-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese
US7512945B2 (en) * 2003-12-29 2009-03-31 Intel Corporation Method and apparatus for scheduling the processing of commands for execution by cryptographic algorithm cores in a programmable network processor
CN100448836C (zh) * 2005-06-03 2009-01-07 浙江中贝化工有限公司 一种抗艾滋病药物关键中间体的制备方法
CN102336758A (zh) * 2005-08-24 2012-02-01 辉瑞有限公司 作为hcv聚合酶抑制剂的化合物及组合物
KR101548306B1 (ko) * 2007-11-30 2015-08-28 가부시키가이샤 한도오따이 에네루기 켄큐쇼 발광 소자, 발광 장치 및 전자기기
US8853393B2 (en) * 2011-07-29 2014-10-07 Anhui New Star Pharmaceutical Development Co., Ltd. Intermediate for preparing tapentadol or analogues thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1355667A (fr) * 1963-02-05 1964-03-20 Meci Materiel Elect Contr Gaine tubulaire pour électrode servant à la mesure du ph
FR1355668A (fr) * 1963-02-05 1964-03-20 Moteur rotatif à combustion interne perfectionné
FR2096877B1 (https=) * 1970-07-09 1973-08-10 Hexachimie
JPH0665657B2 (ja) * 1984-11-08 1994-08-24 日本化薬株式会社 光学活性マンデル酸の製法
JPH072677B2 (ja) * 1988-02-19 1995-01-18 株式会社クラレ (±)―2―ヒドロキシ―4―フェニルブタン酸の光学分割法
JPH01221345A (ja) * 1988-02-27 1989-09-04 Ajinomoto Co Inc マンデル酸誘導体の光学分割方法
JP3084577B2 (ja) * 1991-09-27 2000-09-04 山川薬品工業株式会社 光学活性なアトロラクチン酸の製造方法および製造の中間体
JP3178086B2 (ja) * 1992-06-17 2001-06-18 山川薬品工業株式会社 光学活性α−メチルベンジルアミンの製造方法
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
DE69433705T2 (de) * 1993-11-19 2005-03-10 Parke, Davis & Company 5,6-Dihydropyronderivate als Proteaseinhibitoren und Antiviralmittel
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
RU2074169C1 (ru) * 1995-05-10 1997-02-27 Акционерное общество открытого типа "Химпром" Способ получения этилового эфира п-нитробензойной кислоты

Similar Documents

Publication Publication Date Title
JP5800834B2 (ja) ハリコンドリンb類似体の合成において有用なフロ[3,2−b]ピラン誘導体
JP2001515895A5 (https=)
EP1200384B1 (de) 2-alkyl-5-halogen-pent-4-encarbonsäuren und deren herstellung
JP2013533291A5 (https=)
CN1113485A (zh) 含取代的吡啶基二羟基庚烯酸或其盐的药物的制法
JP2012503621A5 (https=)
JP2010532340A5 (https=)
EP2785687A1 (en) Process for preparation of (3r)-2,4-di-leaving group-3-methylbut-1-ene
CS236484B2 (en) Method of 9-fluorprostaglandine derivatives production
RU2000109277A (ru) Новый способ получения ингибитора протеазы
JP2004529172A5 (https=)
JP2002536450A (ja) エポチロン誘導体、それらの製造方法、及びそれらの医薬としての使用
RU2223958C2 (ru) Новый способ получения ингибитора протеазы
DE69920906T2 (de) Zwischenprodukte in der synthese von epothilonen und verfahren zu deren herstellung
JP2003055368A (ja) ケミカルプロセス
JP2008509896A (ja) 保護化アミノチアゾールのフッ素化方法
JP2006505567A5 (https=)
KR20100102107A (ko) β-뉴클레오시드의 새로운 합성 방법
EP2307369A1 (fr) Réactifs de marquage ayant un noyau pyridine portant une fonction diazométhyle, procédés de synthèse de tels réactifs et procédés de détection de molecules biologiques
DE69715417T2 (de) Oxazolidinester
EP3360866B1 (en) Mirabegron prodrugs
Drag et al. Synthesis of α1-(Cbz-aminoalkyl)-α2-(hydroxyalkyl) phosphinic esters
JP7109056B2 (ja) S-icaリボシルホモシステインの製造方法
FR2551436A1 (fr) 16-fluoro-16,17-dideshydro-prostanoides, procede pour leur preparation, produits intermediaires de leur preparation et leurs utilisations therapeutiques, notamment dans les indications des prostaglandines naturelles
DE10138348A1 (de) Geschützte 3,5-Dihydroxy-2,2-dimethyl-valeroamide für die Synthese von Epothilonen und Derivaten und Verfahren zur Herstellung und die Verwendung